Dechra Pharmaceuticals Plc's (DPH.L) six-month pre-tax profit decreased to 8.9 million pounds from 9.0 million pounds in the prior-year period. On a per share basis, half-yearly earnings improved to 10.06 pence from 10.05 pence a year ago.
Underlying pre-tax profit was 14.3 million pounds compared with 13.9 million pounds achieved in 2010. At constant currency and excluding foreign currency gains and losses, underlying pre-tax profit was £15.1 million, up 11.3% versus 2010. Underlying earnings per share were 15.82 pence, higher than last year's 15.51 pence.
Revenue for the six months ended December 31, 2011 totaled 209.5 million pounds, up 9.0% from 192.2 million pounds in the previous year.
The board also declared an interim dividend of 4.1 pence per share, an increase of 10.8%, payable on 10 April 2012 to Shareholders on the Register of Members at close of business on 9 March 2012. The ordinary shares would become ex dividend on 7 March 2012.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org